The move to remove “potentially stigmatizing or invasive” questions was made to reduce the stigma associated with mental health in the healthcare field and connect workers with needed resources, according to a Dec. 11 news release from the Massachusetts Health and Hospital Association.
The effort was approved unanimously by the association’s board of trustees and was supported by the Massachusetts Medical Society along with local health plans, which each have their own credentialing forms for clinicians.
Meanwhile, the National Committee for Quality Assurance — the organization responsible for accrediting health plans across the country — is no longer requiring plans to ask clinicians about prior drug use.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
